AstraZeneca UK Limited

Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003
Patient Information Leaflet last updated on the eMC: 17/02/2010
PIL Seroquel XL 50mg, 200mg, 300mg, 400mg prolonged-release tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/02/2010 and displayed until Current
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 14/10/2009 and displayed until 17/02/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 20/04/2009 and displayed until 14/10/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 19/09/2008 and displayed until 20/04/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   quetiapine fumarate


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk